Conclusion. Majority of our patients in the study have positive TB culture after two weeks of rifampicin based anti-tuberculosis therapy. So, discontinuation of the isolation after 2 weeks of treatment assuming that bacilli in the smear are nonviable may not be safe.
Treatment of Latent Tuberculosis Infection in a Refugee Population
Background. As tuberculosis (TB) rates decline in the United States, many new cases are among individuals who migrated from countries with a high incidence of TB. Public Health -Dayton & Montgomery County screens incoming refugees for active and latent TB. The objective of this study was to estimate the number of active cases of TB prevented through screening and treatment of LTBI.
Methods. Data were collected through retrospective chart review of refugee seen between July 1, 2011 and June 30, 2015. Refugees younger than 5 years old were excluded. New cases of active TB identified from July 1, 2011 through August 31, 2017 were reviewed for cases in refugees. The number of expected new, active TB cases was 100-150 per 100,000 person-years of follow-up (McBride, MJA 2012) .
Results. A total of 607 charts were reviewed: 373 were males, 234 females. Ages ranged from 6 to 77 years, average 27.4 years. The leading countries of origin were Kenya (79), Iraq (68), Rwanda (59), Ethiopia (55), and Nepal (52). There were three cases of active TB diagnosed on initial evaluation; there were no cases of active TB diagnosed in 2,341 person-years of follow-up. Among refugees, 23.1% had positive T-Spots; highest in the 36-45 age group (35.0%) and refugees from South to East Asia (29.6%). LTBI was diagnosed in 21.1% of refugees; highest in the 46-55 age group (33.3%) and refugees from South to East Asia (27.8%). The majority of subjects with LTBI completed treatment (78.9%). Treatment completion was highest among the 13-17 age group (100.0%), males (81.4%), and refugees from South to East Asia (92.9%); lowest in the >56 age group (40.0%) and European region (50.0%).
Conclusion. Based on published data, an estimated 2.3-3.5 active cases of TB were prevented through this program. Treatment completion rates were higher than reported for non-refugee populations. Results indicate the program is effective at screening for and preventing development of active TB.
Disclosures. Background. Tuberculosis treatment is based on the regular and concomitant intake of several antibiotics. The goal of this multidrug therapy is to prevent the selection of mutants resistant. This combination drug comes in two regimens with dissociated forms (DF) and combined forms (CF). Our study aimed to compare both forms of anti-tubercular treatment.
Methods. We retrospectively collected data from the regional registry of tuberculosis in the government of Sfax as a part of the National Tuberculosis Program. We included all new cases of tuberculosis from January 1995 to December 2016.
Results. We counted 2,771 cases of tuberculosis. There were 59.5% cases with extra-pulmonary (n = 1,650) forms and 40.5% with pulmonary forms (n = 1,121). The median age was 38 years (IQR = [25-55 years]) with a male predominance (n = 1,508; 54.4%). We noted that 72.9% of patients (n = 1,985) received the DF, 26.2% (n = 714) received the CF and 0.8% (n = 23) received both forms of treatment. DF was significantly more prescribed in patients with extra-pulmonary tuberculosis (75.4% vs. 72%; OR = 0.837; P = 0.043) whereas CF was significantly prescribed in patients with pulmonary tuberculosis (28% vs. 24.6%; OR = 0.837; P = 0.043). DF was more used in patients with primary tuberculosis infection (30.3% vs. 21.6%; OR = 0.632; P < 0.001). The duration of treatment was significantly higher in patients who received DF (9 months vs. 8 months; P < 0.001). We did not find a difference in the evolution between patients treated with DF and those treated with CF.
Conclusion. CF are of a great importance to ensure better compliance and synergistic effects of different antibiotics with a reduced duration.
Disclosures. 
